AzTrials
AzTrials

Depression in AdolescenceSCREENSNCT07278752

Social Media Concerns Related to Emotional Experiences in Naturalistic Settings (SCREENS)

An observational study of Depression in Adolescence and Suicidal Ideation, run by University of Texas Southwestern Medical Center at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to advance understanding of the relationships between social media use (SMU) and internalizing symptoms among a diverse sample of depressed and/or suicidal youth. Youth (ages 13-18) enrolled in the TX-YDSRN registry study will be recruited for participation in SCREENS. Read more about this study

Who is it for?
Ages 13 to 18 years
How many people
100 participants
Where
1 siteUnited States
Study dates
26 May 2026to 1 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: This study will leverage the existing Texas Youth Depression and Suicide Research Network (TX-YDSRN) Participant Registry NCT04572321, a natural-history longitudinal data repository of youth with depression and/or suicidal ideation or behavior across 12 Health Related Institutions (HRIs) in Texas. 100 hundred participants aged 13 to 18 years old will be recruited and enrolled in this study.

Who may be able to join

  • Be between 13 and 18 years of age at the time of enrollment.
  • Be currently enrolled in the TX-YDSRN registry study and willing to allow sharing of data from that study.
  • Own a smartphone and agree to download and use the study mHealth application for the duration of study participation.
  • Be willing and able to participate in all study requirements and allocate sufficient time to complete study questionnaires and measures.

Who cannot join

  • Have medical, psychiatric, or other condition for which study participation would not be in their best interest or that could interfere or confound study assessments.
  • Require immediate psychiatric hospitalization or present an imminent suicide risk at the time of screening.
  • Unwilling or unable to download or comply with mHealth app requirements.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75235

Other trials in United States

About this study

The objective of this study is to advance understanding of the relationships between social media use (SMU) and internalizing symptoms among a diverse sample of depressed and/or suicidal youth. Youth (ages 13-18) enrolled in the TX-YDSRN registry study will be recruited for participation in SCREENS. After reviewing the Information Sheet, participants will complete baseline measures assessing internalizing symptoms (e.g., depression, anxiety, suicidal ideation/behavior), and trauma history. They will then complete ecological momentary assessments (EMAs) twice daily for 30 days via the mHealth app, capturing internalizing symptoms, emotional responses to social media, and in-person social support. The mHealth app will also collect the amount of social media use during this 30-day period. From Month 1 through Month 6, participants will receive monthly self-report surveys administered through REDCap.

100 participants

Read more

This study will enroll youth from the TX-YDSRN registry study who meet all the following criteria:

  • Be between 13 and 18 years of age at the time of enrollment.
  • Be currently enrolled in the TX-YDSRN registry study and willing to allow sharing of data from that study.
  • Own a smartphone and agree to download and use the study mHealth application for the duration of study participation.
  • Be willing and able to participate in all study requirements and allocate sufficient time to complete study questionnaires and measures.

Visits include a Screening Visit, Baseline Visit, EMA 2x daily for 30 days, 6 remote follow-up survey visits.

Multiple streams of outcome measures will be utilized for this protocol, including self-report measures, research assessor-completed measure, and EMA measures.

Adverse event (AE) recording, 9 item Patient Health Questionnaire Adolescent Version (PHQ-A), Concise Health Risk Tracking Self Report (CHRT-SR).

Read the detailed description

The study aims to enroll 100 participants recruited from the TX-YDSRN registry study. TX-YDSRN registry study, an ongoing state-wide longitudinal data repository funded by Texas Child Mental Healthcare Consortium (TCMHCC). TX-YDSRN is comprised of 12 participating HRIs across Texas.

Eligible and active TX-YDSRN participants will be invited to participate in this study. Efforts will be made to ensure a diverse and representative sample, including participants of varying sexes, ethnicities, races, and socioeconomic backgrounds. The TX-YDSRN's established recruitment network and community partnerships since 2020 support broad and inclusive enrollment.

Advances in mobile health (mHealth) technologies offer new ways to monitor depression and suicidal ideation outside of clinical settings. Through smartphones and devices from wearable health technology leaders such as Garmin or Fitbit, this study aims to remotely track clinical indicators among youth. These technologies collect data such as physical activity, social interaction, sleep, social media experiences, social media use amount, and mood in real-time, providing an ecologically valid picture of the participants' daily lives. This approach can enhance early detection of clinical deterioration, empowering both participants and caregivers with timely, actionable feedback.

Using HIPAA-compliant software on smartphones, the app will track digital markers such as location, movement, call/text frequency, screen time, and survey responses as proxies for social interaction, in-person social support, anxiety, suicidal ideation/behavior, emotional responses to social media, and mood. Data is encrypted, stored on secure servers ensuring confidentiality. Similarly, wearables will track digital biomarkers such as sleep patterns, heart rate, and activity levels. Together, these metrics offer continuous, longitudinal data on various potential markers for physical and psychological health such as the following:

  • Activity Levels: Reduced physical activity and social engagement may indicate worsening depression. Tracking changes in the radius of daily movement can help detect reduced interest and motivation to engage in important or valued activities.
  • Sleep Patterns: Sleep issues (insomnia, hypersomnia, disruption, restlessness) often signal mood changes. By monitoring sleep latency, duration, and quality, we can identify early warning signs of depression.
  • Social Interaction: Decreases in communication frequency and network size, changes in screen time, can indicate social withdrawal.
  • Mood Variability: Regular assessments of mood, fatigue, and energy help capture emotional variability. Non-responsiveness itself can be a potential marker of worsening of depression.

Social media use amount is passive data that will be collected through mHealth. mHealth will also automatically track duration of app use (seconds) by type of platform and will tell us actual usage (on screen) rather than those running in the background. mHealth will constantly collect data is the app is open and running in the background of the subject's device. These data will be collected constantly for the 1-month period during which Ecological Momentary Assessment Measures (EMA) data are also collected on social media experiences.

Given the study's integration of mobile device monitoring, several strategies will be implemented to enhance participant engagement and retention throughout study participation:

  • Mobile Notifications: Participants will receive Ecological Momentary Assessment (EMA) prompts via their mobile devices multiple times per day. These notifications will remind participants to complete assigned tasks, with automated follow-up reminders to encourage timely completion.
  • Follow-Up for Non-Response: Participants who do not respond to EMA prompts for more than 48 hours will be contacted by research staff via phone, text message, or email. those proactive check ins will aim to re-engage participants, identify potential barriers, and trouble shoot any technical issues (e.g., adjusting notification settings, reinstallation of the app, or supporting participants who have transitioned to a new device).
  • Incentive Structure: A structured incentive plan will be employed to promote consistent engagement and adherence. Participants will be eligible for incremental compensation tied to EMA completion rates, with additional bonus payments provided for high completion percentages across the study period.

Regular communication will be maintained through a combination of phone calls, emails, text messages, and mailed reminders.

Duration of Participation and Visit Schedule Enrollment of 100 subjects is expected to take place over approximately 1 year. Enrolled participants will be involved in the study for 6 months. Visits include a Screening Visit, Baseline Visit, EMA (2 times per day for 30 days), 6 monthly remote follow-up visits.

Outcome Measures Multiple streams of outcome measures will be utilized for this protocol, including self-reported, assessor-completed measures and EMA.

Ecological Momentary Assessment Measures:

The EMA survey administered through the mHealth application will include validated EMA items for Social Media factors of Social Media experiences (positive and negative ERSM) and for social context (adapted from an EMA measure of positive and negative in-person interactions). Primary outcomes will be collected twice daily, morning and evening, and will include items assessing mood and anxiety as well as the 3-item suicidal thoughts subscale of the CHRT-SR16. Participants will answer 5 questions morning and evening related to depression, anxiety, and suicidal ideation. For depression, youth will select which emoticon best represents their current mood (e.g., smiley face, neutral face, frowny face). For anxiety, the question is item 1 from GAD-7. The suicidal ideation questions are items 14-16 on the CHRT-SR16.

Emotional Responses to Social Media (ERSM):

Emotional experiences related to online experiences will be assessed using the Emotional Responses to Social Media (ERSM) scale, which assesses both positive (e.g., "How much did you feel happy or excited because of a positive interaction?") and negative (e.g., "How much did you feel sad or hurt because of a negative interaction?") experiences with social media use. ERSM items include those used in our consultant's prior research and developed based on the ERSM. Four of these items focus on dyadic positive and negative online social interactions. Three items focus on more general social impression. We will explore these separate social media experience constructs to get a more nuanced understanding of types of social media experiences. ERSM questions will only be included in the evening survey.

Questions related to in-person social experiences Items assessing positive and negative in-person interactions will ask participants to think about the most influential offline social interaction they had and rate it as either positive, negative, or mixed. Participants also have the option if they did not have an in-person interaction that day. Based on their response, participants will receive additional questions asking what made the interaction positive or negative and to rate the experience on a scale from 0-10. Questions regarding in-person interactions will only be included in the evening survey.

Further context concerning in-person social experiences will be derived from the Traumatic Events Screening Inventory for Children (TESI-C) clinical interview, which provides information on victimization experiences.

Medical subject headings
Suicidal Ideation, Internet Addiction Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Concise Health Risk Tracking Self-Report (CHRT-SR)

    The CHRT is a scale that evaluates specific thoughts about suicide and thoughts and feelings associated with an increased risk for suicide. The self-report CHRT is a 16-item scale that evaluates specific thoughts about suicide and thoughts and feelings associated with an increased risk for suicide. Its psychometric properties have been well-established in children and adolescents.

    Measured: 6 months

  2. Patient Health Questionnaire-A (PHQ-A)

    The PHQ-A is a nine-item, self-report inventory that assesses for symptoms in all nine symptom domains of a major depressive episode. It is the PHQ-9 modified for adolescents 12-18 years

    Measured: 6 months

  3. Generalized Anxiety Disorder Scale - 7 items (GAD-7)

    The GAD-7 is self-report that assesses for symptoms in 7 symptom domains of generalized anxiety, with an additional question on anxiety-related functional impairment.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2025
  2. Study start26 May 2026
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07278752
Sponsor's protocol ID
STU20252066
Other IDs
R21MH142320-01
Acronym
SCREENS
Status last verified
May 2026
First submitted
19 Nov 2025
Last updated
29 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression in Adolescence and Suicidal Ideation, run by University of Texas Southwestern Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Concise Health Risk Tracking Self-Report (CHRT-SR) (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in